Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-018682

General Counsel acquired 230,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Marlan D General Counsel 2022-03-14 Option exercise +230,000 258,908 D
Derivatives
Walker Marlan D General Counsel 2022-03-14 Option exercise · Restricted Stock Units −230,000 0 D
Loading xslF345X03/doc4.xml…